Start with the current clinical question, not a lifetime NF2 budget
A diagnostic genetics visit, annual surveillance, vestibular-schwannoma surgery, spinal-tumor surgery and systemic bevacizumab are fundamentally different episodes of care. Ask the center to quote the next clinically necessary step. This avoids inflated estimates that combine services the patient may never need.
Genetic cost depends on whether mosaic disease needs tumor analysis
Straightforward germline NF2 testing is different from investigating mosaic NF2-related schwannomatosis. Low variant levels in blood or an unresolved phenotype may require expert interpretation and testing of one or more tumors. Existing pathology blocks, sequencing results and variant allele fractions should be sent before repeating molecular tests.
MRI surveillance can involve brain, internal auditory canals and spine
Imaging cost depends on tumor distribution, prior treatment and the question being answered. A patient may need dedicated brain/IAC MRI, spine MRI or review of existing serial scans rather than a new examination of every region. Sending original DICOM files can allow growth comparison and reduce unnecessary duplication.
Audiology is a core cost driver in vestibular schwannoma planning
Serial pure-tone thresholds, speech discrimination and sometimes vestibular or electrophysiological testing can materially change the treatment decision. In bilateral disease, hearing function in both ears must be considered before surgery or radiation, so audiology should be treated as part of the decision pathway rather than an optional add-on.
Skull-base surgery cost varies with tumor size and nerve-preservation goals
Microsurgery can range from a planned hearing-preservation procedure to decompression of a large tumor with brainstem effects. Cost depends on operative complexity, neurophysiological monitoring, anesthesia, inpatient stay, intensive monitoring when needed and rehabilitation. Previous surgery or bilateral disease can make the planning more complex.
Spinal and peripheral tumor surgery is a separate pathway
A symptomatic spinal schwannoma or ependymoma may require neurosurgical decompression and intraoperative monitoring, while a peripheral nerve tumor may involve specialized nerve surgery. These procedures should not be priced as if they were the same as vestibular-schwannoma surgery.
Stereotactic radiation has its own planning and follow-up costs
Selected tumors may be considered for radiosurgery or fractionated stereotactic radiotherapy. The estimate can include specialist review, planning MRI/CT, dosimetry, treatment delivery and serial follow-up. In NF2-related disease, prior radiation and the possibility of multiple future tumors must be considered before treating a lesion simply because radiation is technically possible.
Bevacizumab is a repeated systemic-treatment and monitoring pathway
University Hospital Düsseldorf publishes an outpatient bevacizumab pathway for selected NF2-associated vestibular schwannomas. Financial planning must account for repeated infusions, clinical and hearing assessment, MRI response evaluation, blood-pressure and renal monitoring and management of adverse effects. Regulatory, reimbursement and self-pay arrangements should be confirmed with the treating center for the individual case.
Hearing rehabilitation can add device and procedure costs
Progressive bilateral hearing loss may lead to conventional hearing devices, cochlear implantation or, in selected cases, auditory brainstem implantation. These are separate candidacy and procedural pathways, and their cost cannot be inferred from the tumor-treatment estimate.
A multidisciplinary NF center can prevent fragmented duplicate work-up
UKE coordinates schwannomatosis through molecular genetics, neurophysiology, tumor volumetry and an interdisciplinary NF board. For a patient with multiple tumors, one coordinated review can be more clinically useful than unrelated appointments with several departments that each repeat history and imaging.
Send these records before requesting a German estimate
The hospital can quote more accurately when it understands which tumor or functional problem drives the visit.
- NF2/schwannomatosis germline testing and tumor-sequencing reports
- Serial brain and internal-auditory-canal MRI DICOM files
- Spine MRI DICOM files
- Audiograms and speech-discrimination results
- Previous surgery and pathology reports
- Radiotherapy/radiosurgery plans and dose summaries
- Current neurological, balance and hearing symptoms
- Current hearing aids or implant history
- Previous bevacizumab/systemic therapy and monitoring
- Exact requested service: diagnostic clarification, surveillance review, surgery opinion, radiation opinion, bevacizumab assessment, spinal-tumor review or hearing rehabilitation
Official sources
Last source-reviewed 2026-09-03. Cost procedures and published service fees can change, so confirm current terms directly with the provider before transferring money or booking travel.
- UKE Neurofibromatosis Clinic – schwannomatosis care — University Medical Center Hamburg-Eppendorf (UKE) ↗
- Updated diagnostic criteria and nomenclature for NF2 and schwannomatosis — Genetics in Medicine / International Consensus Group ↗
- Antibody therapy for NF2-associated vestibular schwannoma — University Hospital Düsseldorf ↗